Type II collagen occurs in the muscles of rectovaginal constriction (RVC) affected and carrier cattle but not in normal cattle. Muscle biopsies from known RVC affected and carrier cattle and normal cattle were examined for the presence of Type II collagen using affinity purified goat anti-collagen II serum in a fluorescent antibody test. Type II collagen was consistently found in RVC affected animals (22 of 23 samples score positive). Rectovaginal constriction carrier animals had variable staining for the Type II collagen (25 of 47 samples scored positive). Some positive staining was also observed in the control animals (8 of 34 samples scored positive). Because of the variable occurrence of Type II collagen, the value of fluorescent antibody staining to identify RVC carrier animals is uncertain.
Rectovaginal constriction (RVC) was first described in Jersey cattle in 1975. 5 Cows affected with RVC have a nonextensible band of tissue surrounding the anus and vaginal vestibule. 8 The presence of this stenosis of the vulvovestibula area results in dystocia at parturition and problems with rectal palpation for pregnancy diagnosis or artificial insemination (AI). In addition, many affected cows develop udder edema at term, which leads to decreased milk production. ' Rectovaginal constriction is believed to be a monofactorial autosomal recessive genetic condition that occurs only in Jersey cattle. 4 The occurrence of the condition has increased with the advent of extensive use of AI. The current problem is the identification of carrier animals, especially bulls used in AI. A study of the possible linkage of RVC gene(s) with blood groups and polymorphic proteins in Jersey cattle in Denmark found no evidence of close linkage of RVC and loci controlling 13 blood groups. 3 When affinity-purified anti-collagen sera were used in a fluorescent antibody procedure to study the occurrence of various collagen types in muscle biopsies from normal and RVC carrier and affected cattle, increased amounts of Types I, III, and IV collagen were found in muscle biopsies of affected animals.' More significantly, that study reported that Type II collagen occurred in the muscle of affected and carrier animals but not in that of normal animals. It was suggested that detection of Type II collagen by fluorescent antibody staining might provide a means to identify the carriers of the RVC gene(s). The purpose of this study was to develop an immunofluorescence test to detect RVC carrier animals.
Materials and methods
Antibody preparations. Affinity-purified goat anti-bovine collagen Type II antibodies were obtained from a commercial source. a The anti-collagen Type II antibody was used at a 1:100 or 1:200 dilution for staining the tissue sections. Fluorescein-labeled rabbit anti-goat IgG antiserum b was absorbed with acetone-precipitated mouse liver powder prior to use. A 1:100 dilution of the anti-goat IgG was used to stain the tissue sections.
Muscle biopsies. Muscle biopsies were from the external anal sphincter muscle of known RVC affected (4 samples) and RVC carrier (7 samples) Jersey cattle (cows and bulls). All the affected animals had been diagnosed as RVC positive by physical examination and met the criteria of the American Jersey Cattle Club. The carriers were either progeny of or parents of RVC affected animals. Negative control biopsy samples were obtained from an Ayrshire, a Holstein, and a Guernsey cow. The biopsy samples were placed on a small piece of tongue depressor and put into Michel's transport medium 6 for transportation to the laboratory.
Tissue preparation. To prepare slides for evaluation of the tissues, a portion of each muscle biopsy sample was placed in a 10% sucrose solution in phosphate-buffered saline (PBS), pH 7.2, for 30 min at room temperature. The tissues were then embedded in embedding medium c and frozen (-20 C) overnight. Sections (6 µm) of the tissues were cut on a refrigerated microtome. Four to 8 sections of each tissue were placed on a chrome-alum-coated slide and dried at room temperature. The slides were incubated at 37 C for 30 min and then frozen at -20 C overnight. Before staining, the slides were warmed to room temperature and washed for 30 min in PBS.
Staining of slides. Each tissue section was covered with a drop of goat anti-bovine collagen Type II antiserum (1:100 dilution in PBS). The slides were incubated in a moist cham- ber at room temperature for 30 min and then washed for 1 hr in PBS. Each tissue section was covered with a drop of fluorescein-labeled rabbit anti-goat IgG antiserum (1:100 dilution in PBS), and the slides were incubated and washed as before. The slides were air dried, and a glass coverslip was mounted using FA mounting fluid d (pH 7.2). The times of each step, dilutions of antiserum used, and specificity of the staining were tested in preliminary studies.
Examination of slides. The stained slides were examined using an ultraviolet light (UV) microscope equipped with epiillumination. The slides were coded before examination and were scored either positive or negative for the presence of Type II collagen. A known positive (known RVC affected animal) and a known negative (control cow sample) slide were included in each group of slides examined as references for the scoring of the coded slides.
Biostatistics. The data were analyzed using an appropriately partitioned 2 x 3 chi-square test. The sensitivity, specificity, and predictive accuracy of the test were calculated using standard techniques. 2
Results
Various combinations of samples from these animals were examined as coded samples at 12 different times. The results of these examinations are summarized in Table 1 . Analysis of the test results using known status demonstrated a significant (x 2 = 13.43, df = 2, P < 0.005) association between the status of the animal and whether or not the test results were correct ( Table  2 ). Partitioning of the groups showed that the carrier group had less association with the correct test results Table 2 . Analysis of the collagen test results of cattle with a known rectovaginal constriction status.* than did the affected and negative classes combined (X 2 = 9.4, df = 1, P < 0.005). Further partitioning of the groups showed that the affected group had a stronger association with the correct test results than did the negative group (x 2 = 4.03, df= 1, P < 0.05). The data in Table 1 were used to calculate the sensitivity and specificity of the fluorescent antibody staining for Type II collagen in determining the status of an animal. The sensitivity of the test was 72.4%, and the specificity was 87.7%. Using the prevalence of the condition in the test population (73.4% affected or carriers), the positive predictive accuracy of the test was 87.7% and the negative predictive accuracy was 47.7%.
Discussion
Fluorescent antibody staining was used to detect the presence of Type II collagen in muscle biopsies from Jersey cattle. Type II collagen occurs in the muscles of RVC affected and carrier cattle but not in muscles of normal cattle. 7 Our results confirm that Type II collagen occurs in the anal sphincter muscle of Jersey cattle affected with RVC (Table 1 ). There was a significant association with the test results (detection of Type II collagen) for the affected-negative group test results (P < 0.005).
Among carrier animals, the association of positive staining for the presence of Type II collagen and RVC carrier status was less clear. In a previous study, RVC carriers had Type II collagen in the muscle but in lower amounts than did affected animals. ' We found what appeared to be variable occurrence of Type II collagen in the RVC carrier animals. Some animals (#203) had consistent staining for Type II collagen, whereas others (#201) appeared to have very little and constantly scored negative in the test ( Table 1 ). All of the carrier animals in the study population were the progeny or parents of affected animals, so their carrier status was not in question. The reason for this apparent variable occur-rence of Type II collagen in RVC carrier animals is unknown. The occurrence of the Type II collagen in RVC carrier animals may be part of the pathogenesis of the disease. However, rather than being a monofactorial recessive genetic condition, the disease may be the result of a closely linked gene cluster. Alternatively, the occurrence of the Type II collagen in the muscle may not be part of the pathogenesis of the condition. A gene controlling the occurrence of the Type II collagen may be closely linked to the gene for RVC. Finally, the occurrence of the Type II collagen in the muscle of the RVC affected and control animals may be part of the disease process, but additional genetic factors may be present that influence the amount of Type II collagen occurring in the muscles.
Detection of Type II collagen has been proposed as a test to identity RVC carrier animals.' Because of the variable occurrence of Type II collagen, the ultimate determination of the value of this procedure in identifying RVC carriers will depend upon analysis of a larger pool of samples from RVC affected, known RVC carrier, and pedigree negative Jersey cattle.
